MedTrace Logo

n3 PUFA and Muscle-disuse Atrophy in Young Women

NCT03059836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-03-22

No results posted yet for this study

Summary

This study will examine the influence of n3 PUFA supplementation on the rate of muscle atrophy in women undergoing 2 weeks of unilateral limb immobilization. Assessments in skeletal muscle strength and skeletal muscle volume will also me made before, after and in recovery from immobilization.

Conditions

  • Muscle Atrophy

Interventions

DIETARY_SUPPLEMENT

n3 PUFA-enriched fish oil

3000mg of Eicosapentaenoic acid per day and 1800mg of Docosahexaenoic acid per day

DIETARY_SUPPLEMENT

Placebo

Organic Sunflower Oil 5000mg per day

Sponsors & Collaborators

Principal Investigators

  • Stuart M Phillips, PhD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-28
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03059836 on ClinicalTrials.gov